These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2888101)

  • 41. Effects of a mixture of peptidase inhibitors (amastatin, captopril and phosphoramidon) on Met-enkephalin-, beta-endorphin-, dynorphin-(1-13)- and electroacupuncture-induced antinociception in rats.
    Kishioka S; Miyamoto Y; Fukunaga Y; Nishida S; Yamamoto H
    Jpn J Pharmacol; 1994 Nov; 66(3):337-45. PubMed ID: 7869621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of amino-terminal sequence of beta-endorphin and dynorphin in the determination of opiate receptor type selectivity.
    Chang JK; Chang KJ
    Life Sci; 1983; 33 Suppl 1():267-9. PubMed ID: 6141489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in the processing of pro-dynorphin end products in the substantia nigra during neonatal development.
    Sei CA; Dores RM
    Peptides; 1990; 11(1):89-94. PubMed ID: 2342993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.
    Dumont M; Lemaire S
    J Mol Cell Cardiol; 1993 Aug; 25(8):983-91. PubMed ID: 7903402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry.
    Bivehed E; Strömvall R; Bergquist J; Bakalkin G; Andersson M
    Peptides; 2017 Jan; 87():20-27. PubMed ID: 27840228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arginine vasopressin enhances periaqueductal gray synthesis and secretion of enkephalin and endorphin in the rat.
    Yang J; Yang Y; Xu HT; Chen JM; Liu WY; Lin BC
    Brain Res Bull; 2006 Dec; 71(1-3):193-9. PubMed ID: 17113946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Influence of microinjection of dynorphin antibody into periaqueductal gray (PAG) on analgesia induced by electroacupuncture of different frequencies in rats].
    He C; Han J
    Zhen Ci Yan Jiu; 1990; 15(2):97-103. PubMed ID: 1980431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.
    Hiranuma T; Kitamura K; Taniguchi T; Kanai M; Arai Y; Iwao K; Oka T
    J Pharmacol Exp Ther; 1998 Aug; 286(2):863-9. PubMed ID: 9694943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [3H] dynorphin binding to guinea pig and rat brain.
    Young E; Walker JM; Houghten R; Akil H
    Life Sci; 1983; 33 Suppl 1():287-90. PubMed ID: 6141490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test.
    Tan-No K; Ohshima K; Taira A; Inoue M; Niijima F; Nakagawasai O; Tadano T; Nylander I; Silberring J; Terenius L; Kisara K
    Brain Res; 2001 Feb; 891(1-2):274-80. PubMed ID: 11164832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat.
    McIntosh TK; Head VA; Faden AI
    Brain Res; 1987 Nov; 425(2):225-33. PubMed ID: 2892572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Penetration of dynorphin 1-13 across the blood-brain barrier.
    Turner TD; Browning JL; Widmayer MA; Baskin DS
    Neuropeptides; 1998 Apr; 32(2):141-9. PubMed ID: 9639252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynorphin A-(1-17) and dynorphin B are released from in vitro superfused rat hypothalami. Effects of depolarizing agents and ovariectomy.
    Spampinato S; Canossa M; Bachetti T; Campana G; Murari G; Ferri S
    Brain Res; 1992 May; 580(1-2):225-32. PubMed ID: 1354557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central changes in nociceptin dynorphin B and Met-enkephalin-Arg-Phe in different models of nociception.
    Rosén A; Lundeberg T; Bytner B; Nylander I
    Brain Res; 2000 Feb; 857(1-2):212-8. PubMed ID: 10700570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test.
    Tan-No K; Taira A; Sakurada T; Inoue M; Sakurada S; Tadano T; Sato T; Sakurada C; Nylander I; Silberring J; Terenius L; Kisara K
    Eur J Pharmacol; 1996 Oct; 314(1-2):61-7. PubMed ID: 8957219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins.
    Molineaux CJ; Ayala JM
    J Neurochem; 1990 Aug; 55(2):611-8. PubMed ID: 1973455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spinal cord dynorphin precursor intermediates decline during late gestation.
    Medina VM; Gupta D; Gintzler AR
    J Neurochem; 1995 Sep; 65(3):1374-80. PubMed ID: 7643115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptors.
    Lee YS; Hall SM; Ramos-Colon C; Remesic M; LeBaron L; Nguyen A; Rankin D; Porreca F; Lai J; Hruby VJ
    Bioorg Med Chem Lett; 2015 Jan; 25(1):30-3. PubMed ID: 25434001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypothalamo-posterior pituitary system in Brattleboro rats: immunoreactive levels of leucine-enkephalin, dynorphin (1-17), dynorphin (1-8) and alpha-neo-endorphin.
    Geis R; Weber E; Martin R; Voigt KH
    Life Sci; 1982 Oct 18-25; 31(16-17):1809-12. PubMed ID: 6130445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.